Jeffrey W. Albers
Overview
Jeffrey W. Albers received an average of $5M in total compensation, including $479K in salary, at Blueprint Medicines from 2014 to 2020.
2020Blueprint MedicinesPresident and Chief Executive Officer
2019Blueprint MedicinesPresident and Chief Executive Officer
2018Blueprint MedicinesPresident and Chief Executive Officer
2017Blueprint MedicinesPresident and Chief Executive Officer
2016Blueprint MedicinesPresident and Chief Executive Officer
2015Blueprint MedicinesPresident and Chief Executive Officer
2014Blueprint MedicinesPresident and Chief Executive Officer
Source: SEC filings on April 21, 2021, April 29, 2020, April 29, 2019, April 27, 2018, April 28, 2017, and April 28, 2016.
Related executives
We found ten more executives who work or worked at Blueprint Medicines.
Fouad Namouni
Blueprint Medicines
President, Research and Development
Kathryn Haviland
Blueprint Medicines
Chief Operating Officer
Tracey McCain
Blueprint Medicines
Chief Legal and Compliance Officer
Michael Landsittel
Blueprint Medicines
Chief Financial Officer
Anthony Boral
Blueprint Medicines
Chief Medical Officer
Christina Rossi
Blueprint Medicines
Chief Commercial Officer
Christopher Murray
Blueprint Medicines
Senior Vice President, Technical Operations
Kate Haviland
Blueprint Medicines